HATFIELD, Pa. Genisphere LLC reported today it has been granted a US patent for a novel strand-specific library preparation method for next generation sequencing based on its proven RNA amplification technology. The new patented process enables amplification and library preparation from clinically relevant RNA samples, adapts easily to a variety of sequencing instruments and systems, […]
Ann Arbor, MI — Rubicon Genomics, Inc. today announced the launch of its PicoPLEX™ DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX’s outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based pre-implantation genetic screening and diagnosis. PicoPLEX DNA-seq now enables researchers and clinicians […]
BILLERICA, Mass — RainDance Technologies, Inc., an innovative genomics tools company ‘democratizing’ molecular testing of complex diseases, today announced that it has developed a comprehensive next-generation sequencing (NGS) panel for profiling actionable cancer mutations, enabling researchers to rapidly and cost-effectively analyze precious biopsy specimens. The ThunderBolts™ Cancer Panel targets 49 known cancer genes, including tumor […]
Westlake, OH — GenomOncology, provider of technology and services for the rapid and interactive analysis and interpretation of Next Generation Sequencing (NGS) data, today announced the investment from TriStar Technology Ventures, a healthcare innovation venture firm, as well as the appointment of John Doulis, CIO of TriStar’s partner fund, MedCare Investment Funds, to the company’s […]
Westlake, OH — GenomOncology today announced that the University of Pittsburgh has selected GenomOncology’s GenomAnalytics™ platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas. Cancer is a complex disease of the genome with each tumor having its own set of genetic anomalies. Increased understanding of the […]
WALTHAM, Mass.–Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows […]
Madison, WI, USA, Roche announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation assessment at single-base resolution. This system includes both a fixed content epigenome-wide design and a full range of custom target offerings. This product line was designed to provide epigenetic researchers with next-generation tools to study DNA methylation with […]
Redwood City, CA — Bina Technologies, the genomic big data science company accelerating personalized medicine, today announced the expansion of their advisory board and commercial team. This announcement marks the latest in the company’s initiatives to significantly improve genomics data analysis workflows used in clinical research. Bina has expanded its Scientific Advisory Board, adding four […]
Quantum Biosystems today announced the release of raw data access to its first reads. The company released reads showing an accuracy of more than 99% in non-homopolymer regions and homopolymer indels at a rate of ~10%. This release allows researchers to evaluate the platform and engage in its validation and development. It marks a major […]
Sony Corporation (“Sony”) today announced that Sony, M3, Inc. (“M3”) and Illumina, Inc. (“Illumina”) have agreed to form a collaboration to launch a “genome information platform” in Japan. Sony and M3 will establish a new company with Illumina as a minority investor, by the end of February, 2014. Genome research, which analyzes human genetic data […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
